Anika Therapeutics, Inc. (ANIK) Total assets 2016–2025
Anika Therapeutics, Inc. (ANIK) total assets at each fiscal year-end, per SEC filings.
$190.3MFY2025 · since FY2016: $240.2M → $190.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $190.3M | -6.2% |
| FY2024 | $202.7M | -25.1% |
| FY2023 | $270.6M | -22.5% |
| FY2022 | $349.1M | +0.5% |
| FY2021 | $347.5M | -4.9% |
| FY2020 | $365.6M | +10.6% |
| FY2019 | $330.7M | +18.5% |
| FY2018 | $279.0M | -1.3% |
| FY2017 | $282.6M | +17.6% |
| FY2016 | $240.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ANIK financial trends
ANIK RevenueANIK Net incomeANIK Net marginANIK Gross profitANIK Gross marginANIK Operating incomeANIK Operating marginANIK Operating cash flowANIK Free cash flowANIK Capital expendituresANIK Return on equityANIK Stock buybacksANIK Dividends paidANIK Total liabilitiesANIK Shareholders’ equityANIK overview →